Andrew Cieri

Andrew Cieri is a seasoned Quality Executive with over 20 years of experience in quality assurance, validation, and manufacturing across GMP, GLP, GDP, and GCP environments. Currently serving as Executive Director of Quality at Regeneron, Andrew oversees quality systems, quality operations and strategy, and Quality Control for the recently formed Regeneron Cell Medicines business unit. He has extensive expertise in developing phase-appropriate, risk-based quality assurance frameworks, ensuring regulatory compliance, and fostering operational excellence. Andrew has successfully navigated complex organizational transitions, including the integration of quality systems during company acquisitions and spinouts, while driving process improvements and reducing costs. His leadership has contributed to multiple regulatory approvals, including FDA and EMA submissions for advanced therapies. Andrew holds a Master of Science in Engineering Management from Tufts University and a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute.